Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why

Zacks' analysis identifies Cardinal Health (CAH) as a strong growth stock, assigning it a Zacks Rank #2 and a Growth Score of A. This assessment is driven by robust projected earnings per share growth of 13.7% this year, significantly outpacing the industry average of 7.6%, alongside an impressive asset utilization ratio of 4.61 compared to the industry's 0.72. Furthermore, CAH's sales are expected to grow 11.4% against an industry average of 4.6%, supported by recent upward earnings estimate revisions. These factors position Cardinal Health as a potential outperformer for growth-oriented investors.

Analysis

Cardinal Health (CAH) presents a compelling growth case, underpinned by strong forward-looking financial metrics and positive analyst sentiment, as reflected in its Zacks Rank #2 (Buy) and 'A' Growth Score. The company's earnings trajectory is a key highlight, with projected EPS growth of 13.7% for the current year, substantially outperforming the industry average of 7.6%. This earnings momentum is further supported by a recent 2.4% upward revision in the Zacks Consensus Estimate over the past month, a signal often correlated with near-term stock appreciation. Operationally, Cardinal Health demonstrates exceptional efficiency, boasting a sales-to-total-assets (S/TA) ratio of 4.61, which indicates it generates significantly more revenue per dollar of assets than the industry average of 0.72. This efficiency complements a robust top-line forecast, with anticipated sales growth of 11.4%, more than double the industry's expected 4.6% growth rate.

Key Decisions for Investors

• Given the combination of double-digit projected earnings growth, superior asset efficiency, and positive analyst estimate revisions, investors with a growth-focused mandate should consider CAH as a potential candidate for outperformance.
• It is critical to monitor upcoming earnings releases to validate whether the company is on track to meet its projected 13.7% EPS and 11.4% sales growth, as these forecasts are central to the current bullish thesis.
• Investors should scrutinize the drivers behind the exceptionally high 4.61 asset utilization ratio to assess its sustainability relative to the industry, as this metric is a key differentiator in the investment case presented.